InsiderTrades

Form 4 for PFE Pfizer

Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-25 · accession 0001225208-23-002984 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-02-28 2023-02-25 PFE Hwang Angela Pres, Gbl Biopharma F - Tax $42.78 -14.8K 38.8K -28% -$631.6K
D 2023-02-28 2023-02-25 PFE Hwang Angela Pres, Gbl Biopharma M - OptEx $22.89 +20.3K 44.5K +84% +$464.0K
D 2023-02-28 2023-02-25 PFE Hwang Angela Pres, Gbl Biopharma M - OptEx $0.00 -20.3K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-25 F D 9,015 $43.44 29,778 D — — (F4) The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). (F5) Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
2 Common Common Stock 2023-02-25 F D 5,748 $41.75 38,793 D — — (F2) The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. (F3) Price is the closing price of Pfizer common stock on February 24, 2023.
3 Common Common Stock 2023-02-25 M A 20,273 $22.89 44,541 D — — (F1) The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
4 Derivative Stock Appreciation Rights 2023-02-25 M D 20,273 $0.00 0 D $22.89 · 2023-02-25 to 2023-02-25 20,273 Common Stock